ZBIO Zenas Corp: Net earnings per share for the last 12 months

Zenas Biopharma Inc (ZBIO) relies on a closed network of research centers that creates significant barriers to entry for competitors. The annual EPS TTM trend captures these processes, with the current level standing at -121.10. However, intense pressure from industry behemoths creates risks for smaller players. Meanwhile, the company complies with environmental regulations by controlling the disposal of laboratory waste.
Financial and market metric breakdowns for Zenas Biopharma, Inc. (ZBIO)

From a portfolio management perspective, this indicator measures the rate of change in net earnings per share over a rolling year, identifying the business's ability to generate value amid liquidity shortages. By analyzing the EPS YoY TTM percentage change trend, an investor assesses the financial stability of Zenas Biopharma Inc (ZBIO), where the efficiency of ESG resource optimization directly impacts cost reduction and final profitability.